{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:13:28Z","timestamp":1781648008067,"version":"3.54.5"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary Sj\u00f6gren\u2019s syndrome (pSS) and breast cancer are a highly prevalent autoimmune disease and malignancy, respectively, both occurring predominantly in females. Whether there is a link between these two diseases is uncertain. We conducted a systematic review and meta-analysis to investigate the risk, incidence, and mortality of breast cancer in patients with pSS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We systematically searched Embase, PubMed, and Web of Science on January 31, 2022 to identify the study that assessed risk, incidence, or mortality of breast cancer in pSS. The fixed or random-effects models were applied to pool the effect estimates based on heterogeneity measured by Cochran\u2019s Q-test and Higgins\u2019 I<jats:sup>2<\/jats:sup>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ten studies involving 725,805 participants and 64,836 pSS patients were included in our analysis. The pooled result showed that, overall, pSS was not associated with the risk (SIR=0.92, 95%CI: 0.66-1.29, <jats:italic>P<\/jats:italic>=0.646) and mortality (HR = 0.78, 95%CI: 0.26-2.34, <jats:italic>P<\/jats:italic> = 0.664) of breast cancer; however, when stratified by geographic region, we found that patients with pSS in Asian countries (SIR=1.32, 95%CI: 1.10-1.58, <jats:italic>P<\/jats:italic>=0.003) and Argentina (SIR=3.76, 95%CI: 1.04-9.45, <jats:italic>P<\/jats:italic>=0.019) had an elevated risk of breast cancer, while pSS in Europe was associated with a reduced risk (SIR=0.61, 95%CI: 0.51-0.73, <jats:italic>P<\/jats:italic>&amp;lt;0.001). The pooled result from 28,635 female pSS patients indicated that the incidence of breast cancer was 2.15 (95% CI: 1.33-3.50) per 1000 person\/years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study suggests that there may be geographical differences in the association between pSS and breast cancer risk; patients with pSS in European countries are associated with a lower risk of breast cancer, while Asia and Argentina are the opposite. Future research is needed to further characterize the effect of pSS on breast cancer risk and the pathophysiological mechanisms underlying this association to unravel the complex relationship between the two.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.904682","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T05:29:30Z","timestamp":1656653370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk, Incidence, and Mortality of Breast Cancer in Primary Sj\u00f6gren\u2019s Syndrome: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Jian","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sj\u00f6gren Syndrome","volume":"344","author":"Ramos-Casals","year":"2012","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of Primary Sj\u00f6gren\u2019s Syndrome: A Systematic Review and Meta-Analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00102\/full","article-title":"Lymphoma and Lymphomagenesis in Primary Sj\u00f6gren\u2019s Syndrome","volume":"5","author":"Alunno","year":"2018","journal-title":"Front Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-04992-x","article-title":"Association Between Comorbidities and Extraglandular Manifestations in Primary Sj\u00f6gren\u2019s Syndrome: A Multicenter Cross-Sectional Study","volume":"39","author":"Zhang","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and Risk Estimate of Cancer in Patients With Primary Sj\u00f6gren Syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"102987","DOI":"10.1016\/j.autrev.2021.102987","article-title":"Cancer Incidence in Primary Sj\u00f6gren\u2019s Syndrome: Data From the French Hospitalization Database","volume":"20","author":"Goulabchand","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13927","article-title":"Risk of Malignancy in Korean Patients With Primary Sj\u00f6gren\u2019s Syndrome","volume":"23","author":"Kang","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and Other Malignancies in Primary Sj\u00f6gren\u2019s Syndrome: A Cohort Study on Cancer Incidence and Lymphoma Predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04433-2","article-title":"Incidence of Cancer in a Cohort of Patients With Primary Sj\u00f6gren Syndrome in Argentina","volume":"39","author":"Brom","year":"2019","journal-title":"Rheumatol Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.191027","article-title":"Bidirectional Relationship Between Primary Sj\u00f6gren Syndrome and Non-Hodgkin Lymphoma: A Nationwide Taiwanese Population-Based Study","volume":"47","author":"Wang","year":"2020","journal-title":"J Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000003540","article-title":"Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases","volume":"95","author":"Yu","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2106-375","article-title":"The Risk of Cancer in Patients With Primary Sj\u00f6gren Syndrome; A Single-Center Study From Turkey","author":"Aslan","year":"2021","journal-title":"Turkish J Med Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.07.100","article-title":"Effect of Autoimmune Diseases on Risk and Survival in Female Cancers","volume":"127","author":"Hemminki","year":"2012","journal-title":"Gynecol Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31148","article-title":"Autoimmune Diseases and Breast Cancer Risk by Tumor Hormone-Receptor Status Among Elderly Women","volume":"142","author":"Schairer","year":"2017","journal-title":"Int J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203305","article-title":"Primary Sj\u00f6gren\u2019s Syndrome and Malignancy Risk: A Systematic Review and Meta-Analysis","volume":"73","author":"Liang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"453012","DOI":"10.1155\/2014\/453012","article-title":"Breast Cancer Risk in Rheumatoid Arthritis: An Update Meta-Analysis","volume":"2014","author":"Tian","year":"2014","journal-title":"BioMed Res Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3950-9","article-title":"No Association Between the Risk of Breast Cancer and Systemic Lupus Erythematosus: Evidence From a Meta-Analysis","volume":"37","author":"Rezaieyazdi","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.4847","article-title":"The Risk of Cancer in Patients With Psoriasis a Population-Based Cohort Study in the Health Improvement Network","volume":"152","author":"Fuxench","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06053-x","article-title":"Indications and Risk Factors for Hospitalization in Patients With Primary Sj\u00f6gren Syndrome: Experience From a Tertiary Center in Turkey","volume":"41","author":"Yayla","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-20-0178","article-title":"Breast Cancer Risk and Use of Nonsteroidal Anti-Inflammatory Agents After a Benign Breast Biopsy","volume":"13","author":"Sherman","year":"2020","journal-title":"Cancer Prev Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.08.024","article-title":"Malignancy Risk in Patients With Inflammatory Eye Disease Treated With Systemic Immunosuppressive Therapy: A Tertiary Referral Cohort Study","volume":"122","author":"Yates","year":"2015","journal-title":"Ophthalmology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.904682\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T05:29:32Z","timestamp":1656653372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.904682\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2022.904682"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.904682","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"article-number":"904682"}}